Thecompoundwas prepared upon reacting Re(CO) 5 Cl with the symmetric twofold Schiff-base derived from salicylaldehyde and 1,3-diaminopropan-2-ol in toluene. Crystals suitable forthe diffraction studywereobtaineduponfreeevaporation of thesolvent at room temperature.
Discussion
Next to cardiovascular diseases, cancer has become one of the main fatal diseases in industrialized countries. Apart from classicalsurgery,chemo-and radiotherapeutic treatments have entered the arsenal of possible cures for certain types of cancer. All methods, however, suffer from theirown setofproblematic side-effects and, as aconsequence, the development of radio-pharmaceuticals -combining the advantages of chemotherapy as well as radiation methods while at the sametimeavoiding their unique respective undesiredside-effects -has been atopic of research [1, 2] .T ailoring andf ine-tuning of thee nvisionedr adiopharmaceuticals' properties such as lipophilicityand,inparticular, inertness is of paramountimportancewithrespect to possible future in vivo applications in contemporary medicine and requires sound knowledge about structural parameters of the ligands applied if a more heuristic approach in the synthesis is to triumph over pure trial-and-error as it is encountered in this specific field of coordination chemistry up to the present day. In continuation of our interest in rhenium-based coordination compounds that might serve as radiopharmaceuticals,arhenium(I) starting materialw as reacted with at wofold Schiff-base derived from salicylaldehyde and 1,3-diaminopropan-2-ol. The structural analysis of the compound showed the formation of amononu-clear rhenium(I) coordination compound withamodified ligand system.S imilar compounds featuring acomparable set of donor atomshave been reported in the literature already [3] [4] [5] .The octahedral coordination sphere around the central atom is created by three carbonyl ligands in fac configuration as well as apartially hydrolyzed derivative of the initially two-fold Schiff-base ligand acting as an O,N,N' donor. In addition, half amolecule of toluene is present in the crystal structure of the title compound. The least-squares planes as defined by the respective non-hydrogen atomso ft he phenyl group on the one hand and the atomsofthe six-membered chelate ring involving the oxygen atom enclose an angle of 22.47(11)°. Apuckering analysis of the two six-membered chelate rings according to Cremer &P ople [6]s hows the oxygencontaining ring to adopt a B C(12),Re(1) conformation while the chelate ring solely applying nitrogen atomsasdonor atomsispresent in a C (3) C Re(1) conformation [7] .T he Re-CO distances cover a range of 1.906 (3) found for the Re-CO bonds in the title compound are among the most commonones reported. The C=N bond is (E)-configured. In the crystal, classical hydrogen bonds of the O-H×××Oa nd the N-H×××Otype are observed. The O-H×××Ocontacts apply the phenolic oxygen atom as acceptor while the N-H×××Ocontacts have theoxygen atom of the OH groupasend point. Thelattercould also be considered as acceptor for aC-H×××Ocontact supported by the hydrogen atom in ortho position of the phenolic oxygen atom. In total, the rhenium-containing entities are connected to chains along the crystallographic b axis. In terms of graph-set analysis [9, 10] , the descriptor for thec lassical hydrogen bonds is R (7) 0.0080 (7) 0.0028 (7) O (2) 8f -0.00112 (8) 
